Login to Your Account

Biopharma sector posts scary market performance in October

By Peter Winter

Monday, November 6, 2017

The biopharma sector's blue chip companies unfortunately got into the Halloween spirit, with the BioWorld Biopharmaceutical index posting a 7 percent swoon in value in October. That performance could be enough to scare investors into remaining on the sidelines for the rest of the year. They may be thinking that the great run biopharmaceutical companies have had this year may have finally run out of steam. In addition, the general markets offer attractive alternatives right now. 

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription